#USA #Center Valley #Olympus #Prostate Health #iTind

Introduction

In September, coinciding with National Prostate Health Month, Olympus Corporation of the Americas has unveiled its revolutionary iTind™ Center of Excellence (COE) program. This initiative aims to improve care, experiences, and outcomes for men who deal with benign prostatic hyperplasia (BPH), commonly referred to as enlarged prostate.

What is the iTind Procedure?

The iTind procedure offers a minimally invasive solution to alleviate lower urinary tract symptoms resulting from BPH. It utilizes a nitinol device that is temporarily implanted within the urinary tract, providing quick relief for symptoms. Notably, this procedure does not necessitate any surgery that involves cutting or removing tissue, making it possible to be conducted in an outpatient setting or an office, under local or general anesthesia. Most patients can go home the same day and typically do not require a catheter.

The Inaugural COE Members

The inaugural members of the iTind Center of Excellence include three esteemed urologists: Dr. C. Cragin Anderson, Dr. Petar Bajic, and Dr. Alex M. Kandabarow. Each has demonstrated a commitment to enhancing patient care through the iTind procedure. According to Matt Woodward, the Vice President and Regional Business Lead for Urology at Olympus, these experts are pivotal in providing safe and effective treatment alternatives to alleviate urinary symptoms that hinder the quality of life for many men.

Standards for COE

To achieve the distinction of being part of the iTind Center of Excellence, participating urologists must fulfill specific benchmarks. These include completing specialized training in the iTind procedure, maintaining clinical competence by completing a required number of procedures yearly, and presenting de-identified patient data that illustrates meaningful symptom improvement. This structured approach ensures that patients receive the highest standard of care.

Importance of the Program

With the growing population of men experiencing BPH, the introduction of the iTind Center of Excellence is a significant step towards addressing their needs efficiently. Many patients remain unaware of non-invasive alternatives to traditional medications and surgical options. Initiatives like the COE program aim to bridge this knowledge gap, facilitating access to innovative treatments. Patients deserving quality care can be referred to the iTind Physician Finder to locate practitioners who specialize in this advanced procedure.

The Future of BPH Treatment

The benefits of the iTind procedure are compelling, offering rapid relief for many individuals suffering from urinary symptoms associated with BPH. By providing effective alternatives for those reluctant to use pharmaceutical solutions or who are not yet ready for surgery, the iTind device is well-positioned to become a primary treatment option for managing BPH symptoms.

About Olympus Corporation

Olympus is a global leader in medical technology, dedicated to enhancing the quality of life by partnering with healthcare professionals. The organization develops solutions aimed at early detection, diagnosis, and minimally invasive treatment, striving to uplift patient outcomes and advance standard care across various health issues.

In summary, the introduction of the iTind Center of Excellence not only marks a notable advancement in the treatment of enlarged prostate symptoms but also underscores Olympus's commitment to patient-centered care and medical innovation. As more urologists are trained and participate in this program, the medical community moves closer to providing effective solutions to improve the well-being of men suffering from BPH.